High-dose of ascorbate inhibited cell proliferation and tumor growth through ROS-dependent inhibition of the MAPK/ERK and PI3K/AKT pathways in thyroid cancer 42. This evidence concerns the gene AKT1 and thyroid gland carcinoma.